PIRAMAL PHARMA LIMITED — Call Transcript 2023

May 29, 2023

==> picture [145 x 60] intentionally omitted <==

29[th] May, 2023

BSE Limited P.J. Towers, Dalal Street, Fort, Mumbai- 400 001 BSE scrip code: 543635

National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051 NSE symbol: PPLPHARMA

Sub: SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ‘ ’ - ( Listing Regulations ) Transcript of Conference Call with Investors/Analysts

Dear Sir / Madam,

Further to our intimation made earlier and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Conference Call held on 25[th] May, 2023 on the financial results (Standalone and Consolidated) of the Company for the quarter and year ended 31[st] March, 2023.

The transcript of the said conference call is also hosted on the website of the Company at https://www.piramal.com/investor/piramal-pharma-limited/financial-reports/investor-calls/

Kindly take the above on record.

Thanking you,

Yours truly,

For Piramal Pharma Limited

Digitally signed TANYA by TANYA SANISH SANISH Date: 2023.05.29 14:45:57 +05'30' Tanya Sanish Company Secretary

Piramal Pharma Limited

CIN: U24297MH2020PLC338592 Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India T +91 22 3802 3000 / 4000

piramal.com